CTE - Cardiotech Intl. Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : CTE - Cardiotech Intl.

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: bvortex who started this subject	10/4/2000 11:19:39 AM
From: bvortex	Read Replies (1) of 6

CTE sells off Vasculink and Myolinks grafts to Nervation for $7MM in cash and $5MM in polymer graft material supply contract. Allows CTE to concentrate on CABG (Cardiac Artery Bypass Graft) with no long-term debt and new cash infusion. CTE has applied to FDA for pre-clinical trial for CABG and to ask for exemption on certain requirements based on past trial data for Vasculink/Myolink graft data. Stay tuned. LONG CTE

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next